Synthetic Biology Market: Size, Share, Trend analysis And Forecast for the period during 2022-2030.
Synthetic Biology Market |
Synthetic biology refers to the
process of redesigning existing organisms to serve new functions. It involves
an interdisciplinary field of study that aims to develop novel biological
components, machinery, and systems or to remodel existing natural systems.
Synthetic biology is being used by researchers to create new tools, services,
and products that offer substantial and genuine benefits.
The Synthetic
Biology Market is anticipated to reach a value of US$ 13.9 billion in
2022 and grow at a CAGR of 28.0% from 2022 to 2030.
Market Dynamics
The Synthetic Biology Market has been experiencing significant growth
in recent years and is expected to continue its upward trajectory in the coming
years. This emerging field combines biology and engineering principles to
design and construct new biological parts, devices, and systems for various
applications.
Synthetic biology involves the
manipulation of biological components such as genes, proteins, and cells to
create novel functionalities and improve existing biological systems. It has
gained considerable attention across multiple sectors, including healthcare,
agriculture, energy, and industrial manufacturing.
Market Drivers
One of the key drivers of the Synthetic Biology Market is the
increasing demand for sustainable solutions and alternatives to traditional
manufacturing processes. Synthetic biology offers the potential to produce
bio-based materials, chemicals, and fuels using renewable resources, thereby
reducing dependence on fossil fuels and minimizing environmental impact.
Market Segmentation;-
·
Oligonucleotides, enzymes, synthetic cells, and other
products
·
DNA sequencing, genome engineering, and other
technological advances Others
·
Academics and research institutions, the biotechnology
and pharmaceutical industries, and others are the end users.
Geographical areas Included:-
·
Americas: United States and Canada
·
Brazil, Argentina, Mexico, and the remainder of Latin
America
·
Germany, the United Kingdom, Spain, France, Italy,
Russia, and the rest of Europe
·
China, India, Japan, Australia, South Korea, ASEAN,
and the rest of Asia Pacific comprise Asia Pacific.
·
GCC nations, Israel, and the remaining Middle Eastern
nations Africa: South Africa, North Africa, and Central Africa
Competitive Landscape
Thermo Fisher Scientific, Synbio
Technologies, Merck KGaA, Agilent Technologies, Inc., GenScript, Amyris,
Eurofins Genomics GmbH, Integrated DNA Technologies, Inc., Codexis, Inc.,
EnBiotix, Inc., Synthego, New England Biolabs (UK) Ltd., Scarab Genomics, LLC,
and Genomatica, Inc. are just a few of the companies that are the key players in this industry.
Comments
Post a Comment